![Paul Whitney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Whitney
Chief Executive Officer at Parallel Private Equity LLP
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Neil Peters | M | - |
Parallel Private Equity LLP
![]() Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 25 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Alexander Dunbar Morrison | M | - |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 6 years |
Peter Robin Blower | M | 75 |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 7 years |
Yuk Fu Chen | M | 75 |
University of Aston
| 7 years |
Geoffrey Guy | M | 70 |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 8 years |
Alistair Taylor | M | - |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 6 years |
Zoe Karen McGowan | F | - |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 13 years |
Graham S. Cox | M | 61 |
Parallel Private Equity LLP
![]() Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 16 years |
Yee Tak Leung | M | 75 |
University of Aston
| 1 years |
Kai Ming Choi | M | 74 |
University of Aston
| 4 years |
George C. Hancock | M | 79 |
Cranfield University
| 2 years |
Alan Bowen | M | - |
Parallel Private Equity LLP
![]() Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 5 years |
Howard Sinclair-Jones | M | - |
University of Aston
| 3 years |
Mahadev Raman | M | - |
Cranfield University
| 1 years |
Tai-Chiu Lee | M | 79 |
University of Aston
| 3 years |
Liyanarachige Tillekeratne | M | - |
University of Aston
| 1 years |
Paul Cyril Warwick | M | 71 |
Cranfield University
| 1 years |
Ahmad Khayyat | M | - |
University of Aston
| 4 years |
Michael Wright | M | 70 |
University of Aston
| 3 years |
Ah Kiow Fu | M | 76 |
Cranfield University
| 1 years |
Alan Moore | M | - |
University of Aston
| 3 years |
Stephen Leftly | M | - |
University of Aston
| 4 years |
Nick Rouse | M | - |
University of Aston
| 4 years |
Farhan Sharaff | M | - |
University of Aston
| 3 years |
J. Graham Eacott | M | - |
University of Aston
| 1 years |
Trevor H. Flanagan | M | - |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | - |
Gordon K. G. Stevens | M | - |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | - |
Richard Peter Dixey | M | - |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | - |
Grant Haggith | M | - |
Parallel Private Equity LLP
![]() Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 14 years |
Alastair Graham Donald | M | 70 |
Cranfield University
| 2 years |
Christopher Charles Allner | M | 65 |
3i Plc
![]() 3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | - |
Piers John Morgan | M | 57 |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 1 years |
John Mackie | M | 70 |
Parallel Private Equity LLP
![]() Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 9 years |
Colin Stott | M | 57 |
Phytopharm Plc
![]() Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 34 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Whitney
- Personal Network